Retinoid targets in cancer therapy and chemoprevention

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Retinoids, derived from vitamin A, are recognized for their therapeutic and chemopreventive roles in cancer.
• They exert biological effects including anti-proliferation, differentiation induction, and apoptosis via nuclear retinoid receptors.
• Direct retinoid targets are genes with responsive elements in their promoters, directly regulated by retinoids.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying retinoid action in cancer therapy and chemoprevention.
• To identify direct retinoid target genes and understand their role in mediating retinoid's biological effects.
• To explore the involvement of proteolytic pathways and specific enzymes in retinoid-induced cellular responses.

Main Methods:

• In vitro studies utilizing cell models to investigate retinoid mechanisms.
• Microarray analysis to identify genes involved in retinoid response, such as UBE1L.
• Analysis of cell cycle regulation, protein degradation pathways (proteasome), and specific target genes like EGFR.

Main Results:

• Retinoid treatment activates the proteasome-dependent degradation pathway, crucial for tumor cell differentiation and chemoprevention.
• In acute promyelocytic leukemia (APL), all-trans-retinoic acid (RA) degrades the oncogenic PML-RARalpha protein.
• Retinoids induce G(1) cell cycle arrest in bronchial epithelial cells, linked to cyclin degradation and DNA repair, and target the epidermal growth factor receptor (EGFR).

Conclusions:

• Retinoids exert diverse biological effects through distinct target genes, impacting cell proliferation, differentiation, and apoptosis.
• Proteolytic mechanisms, particularly proteasome-dependent degradation, are key mediators of retinoid's anti-cancer activities.
• Identifying specific retinoid target genes is essential for a deeper molecular understanding of retinoid response and resistance in cancer treatment and prevention.